RE: Reasons to be cheerful going into Tuesday ..16 Apr 2023 19:20
Great post Sage. Thinking about your EBITDA point it's quite hard to consider why THGs EBITDA wouldn't go at-least back to the FY2021 - 161m range achieved previously. Obv atm the consensus on THGs site is only predicting £120 million EBITDA for FY2023.
When you compare now to FY2021 and consider whey prices are currently lower than FY2021 (let alone 2022 of which they are half those prices), transportation costs are back down to below 2021 levels, they now have automated their New Jersey warehouse and also consider they have Bentley Labs supplier as a full year cost save for FY2023 versus FY2021 (as it was bought in June 2021 therefore only "cost saving" for half of that year).
The only negative would be that labour costs are higher now than FY2021.
Revenue consensus is currently £2,287.1 billion versus FY2021 £2,180 billion. So a £107 million revenue improvement which should theoretically be "better" revenue than FY 2021 due to the discontinuation of certain loss making elements of THG.
All these things considered mean if FY2023 is predicted to be less EBITDA than FY2021s £161 million it would really need to be explained why as it wouldn't seem to make sense. They consistently achieved EBITDA of 9-10% between FY 2017 - FY2020. 9.5% on 2023 consensus revenue should get them £217 million EBITDA. I don't really see why they shouldn't be hitting at least £200 million EBITDA with whey at 5 year lows and this consensus 2023 revenue as I said theoretically being "better" revenue.